ID | Title |
e20660 | Molecular analysis of cell-free DNA to identify distinct molecular mutational burden and its effect on first-line chemotherapy in patients with NSCLC from a phase III trial |
e20011 | Prognostic value of a 12-gene signature in platinum-based chemotherapy treated SCLC |
board#312 abstr 2070 | Detection of tumor-derived DNA mutations in cerebrospinal fluid of patients with primary or metastatic brain tumors |
e23086 | Research on the diversity of T cell receptor repertoire in the process of malignant transformation of HBV chronic infection |